Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders
- PMID: 29988908
- PMCID: PMC6033743
- DOI: 10.5498/wjp.v8.i2.51
Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders
Abstract
Glutamate is the predominant excitatory neurotransmitter in the human brain and it has been shown that prolonged activation of the glutamatergic system leads to nerve damage and cell death. Following release from the pre-synaptic neuron and synaptic transmission, glutamate is either taken up into the pre-synaptic neuron or neighbouring glia by transmembrane glutamate transporters. Excitatory amino acid transporter (EAAT) 1 and EAAT2 are Na+-dependant glutamate transporters expressed predominantly in glia cells of the central nervous system. As the most abundant glutamate transporters, their primary role is to modulate levels of glutamatergic excitability and prevent spill over of glutamate beyond the synapse. This role is facilitated through the binding and transportation of glutamate into astrocytes and microglia. The function of EAAT1 and EAAT2 is heavily regulated at the levels of gene expression, post-transcriptional splicing, glycosylation states and cell-surface trafficking of the protein. Both glutamatergic dysfunction and glial dysfunction have been proposed to be involved in psychiatric disorder. This review will present an overview of the roles that EAAT1 and EAAT2 play in modulating glutamatergic activity in the human brain, and mount an argument that these two transporters could be involved in the aetiologies of schizophrenia and affective disorders as well as represent potential drug targets for novel therapies for those disorders.
Keywords: Affective disorders; Excitatory amino acid transporter; Glia; Glutamate; Glutamate transporter; Psychiatry; Schizophrenia.
Conflict of interest statement
Conflict-of-interest statement: The authors declare no conflicts of interest for this article.
Figures

Similar articles
-
Excitatory amino acid transporter (EAAT)1 and EAAT2 mRNA levels are altered in the prefrontal cortex of subjects with schizophrenia.J Psychiatr Res. 2020 Apr;123:151-158. doi: 10.1016/j.jpsychires.2020.02.004. Epub 2020 Feb 8. J Psychiatr Res. 2020. PMID: 32065951
-
Links between L-glutamate transporters, Na+/K+-ATPase and cytoskeleton in astrocytes: evidence following inhibition with rottlerin.Neuroscience. 2013 Dec 19;254:335-46. doi: 10.1016/j.neuroscience.2013.09.043. Epub 2013 Oct 1. Neuroscience. 2013. PMID: 24095695
-
The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings.J Neurochem. 2003 Feb;84(3):522-32. doi: 10.1046/j.1471-4159.2003.01553.x. J Neurochem. 2003. PMID: 12558972
-
Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.Neurochem Res. 2015 Feb;40(2):380-8. doi: 10.1007/s11064-014-1391-2. Epub 2014 Jul 27. Neurochem Res. 2015. PMID: 25064045 Free PMC article. Review.
-
The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders.Metab Brain Dis. 2023 Jan;38(1):1-16. doi: 10.1007/s11011-022-01091-5. Epub 2022 Sep 29. Metab Brain Dis. 2023. PMID: 36173507 Review.
Cited by
-
The Protective Role of Glutathione on Zinc-Induced Neuron Death after Brain Injuries.Int J Mol Sci. 2023 Feb 2;24(3):2950. doi: 10.3390/ijms24032950. Int J Mol Sci. 2023. PMID: 36769273 Free PMC article. Review.
-
Post-translational protein modifications in schizophrenia.NPJ Schizophr. 2020 Mar 2;6(1):5. doi: 10.1038/s41537-020-0093-9. NPJ Schizophr. 2020. PMID: 32123175 Free PMC article. Review.
-
A monocarboxylate transporter-dependent mechanism confers resistance to exercise-induced fatigue in a high-altitude hypoxic environment.Sci Rep. 2023 Feb 20;13(1):2949. doi: 10.1038/s41598-023-30093-1. Sci Rep. 2023. PMID: 36807596 Free PMC article.
-
Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System.Int J Mol Sci. 2019 Nov 12;20(22):5671. doi: 10.3390/ijms20225671. Int J Mol Sci. 2019. PMID: 31726793 Free PMC article. Review.
-
Host cell proteins modulated upon Toxoplasma infection identified using proteomic approaches: a molecular rationale.Parasitol Res. 2022 Jul;121(7):1853-1865. doi: 10.1007/s00436-022-07541-4. Epub 2022 May 13. Parasitol Res. 2022. PMID: 35552534 Review.
References
-
- Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr. 2000;130:1007S–1015S. - PubMed
-
- Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem. 1984;43:1369–1374. - PubMed
-
- Lehmann A, Isacsson H, Hamberger A. Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus. J Neurochem. 1983;40:1314–1320. - PubMed
-
- Bouvier M, Szatkowski M, Amato A, Attwell D. The glial cell glutamate uptake carrier countertransports pH-changing anions. Nature. 1992;360:471–474. - PubMed
-
- Erecińska M, Silver IA. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol. 1990;35:245–296. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials